222 related articles for article (PubMed ID: 22610315)
1. Carbohydrate to carbohydrate interaction in development process and cancer progression.
Handa K; Hakomori SI
Glycoconj J; 2012 Dec; 29(8-9):627-37. PubMed ID: 22610315
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization.
Hakomori S
Glycoconj J; 2004; 21(3-4):125-37. PubMed ID: 15483378
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501
[TBL] [Abstract][Full Text] [Related]
5. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.
Regina Todeschini A; Hakomori SI
Biochim Biophys Acta; 2008 Mar; 1780(3):421-33. PubMed ID: 17991443
[TBL] [Abstract][Full Text] [Related]
6. GM2/GM3 controls the organizational status of CD82/Met microdomains: further studies in GM2/GM3 complexation.
Santos RCM; Lucena DMS; Loponte HFBR; Alisson-Silva F; Dias WB; Lins RD; Todeschini AR
Glycoconj J; 2022 Oct; 39(5):653-661. PubMed ID: 35536494
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249
[TBL] [Abstract][Full Text] [Related]
8. Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction.
Kojima N; Hakomori S
J Biol Chem; 1991 Sep; 266(26):17552-8. PubMed ID: 1894638
[TBL] [Abstract][Full Text] [Related]
9. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions.
Kawashima N; Yoon SJ; Itoh K; Nakayama K
J Biol Chem; 2009 Mar; 284(10):6147-55. PubMed ID: 19124464
[TBL] [Abstract][Full Text] [Related]
11. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K
Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor.
Yoon SJ; Nakayama K; Hikita T; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):18987-91. PubMed ID: 17142315
[TBL] [Abstract][Full Text] [Related]
13. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells.
Iwabuchi K; Yamamura S; Prinetti A; Handa K; Hakomori S
J Biol Chem; 1998 Apr; 273(15):9130-8. PubMed ID: 9535903
[TBL] [Abstract][Full Text] [Related]
14. Specific interaction between gangliotriaosylceramide (Gg3) and sialosyllactosylceramide (GM3) as a basis for specific cellular recognition between lymphoma and melanoma cells.
Kojima N; Hakomori S
J Biol Chem; 1989 Dec; 264(34):20159-62. PubMed ID: 2584211
[TBL] [Abstract][Full Text] [Related]
15. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
16. GM3 and cancer.
Hakomori SI; Handa K
Glycoconj J; 2015 Feb; 32(1-2):1-8. PubMed ID: 25613425
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of membranes simulating "glycosignaling domain" and their susceptibility to lyso-GM3.
Iwabuchi K; Zhang Y; Handa K; Withers DA; Sinaÿ P; Hakomori S
J Biol Chem; 2000 May; 275(20):15174-81. PubMed ID: 10809752
[TBL] [Abstract][Full Text] [Related]
18. Interaction of N-linked glycans, having multivalent GlcNAc termini, with GM3 ganglioside.
Yoon SJ; Nakayama K; Takahashi N; Yagi H; Utkina N; Wang HY; Kato K; Sadilek M; Hakomori SI
Glycoconj J; 2006 Dec; 23(9):639-49. PubMed ID: 17115280
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
Mirkin BL; Clark SH; Zhang C
Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
[TBL] [Abstract][Full Text] [Related]
20. Glycosyl conjugates of biotinylated diaminopyridine applied for study of carbohydrate-to-carbohydrate interaction.
Utkina N; Yoon SJ; Hakomori SI
Glycoconj J; 2010 Aug; 27(6):601-11. PubMed ID: 20697955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
